RT Journal Article SR Electronic T1 Integrating epidemiological and clinical predictors of SARS-CoV-2 infection in students and school staff in the state of São Paulo JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2021.06.21.21259213 DO 10.1101/2021.06.21.21259213 A1 Fredi A. Diaz Quijano A1 José Mário Nunes da Silva A1 Tatiana Lang D’Agostini A1 Jéssica Pires de Camargo A1 Nathalia Cristina Soares Franceschi Landi de Moraes A1 Ricardo Haddad A1 Maria Cecília Gomes Pereira A1 Dimas Tadeu Covas A1 Regiane A. Cardoso de Paula YR 2021 UL http://medrxiv.org/content/early/2021/06/25/2021.06.21.21259213.abstract AB Background There is a great deal of uncertainty concerning which contexts would be safe for returning to school and about individual criteria that would reduce contact between the infected and susceptible people in the school setting. Therefore, the purpose of this study was to estimate the prevalence of infection by SARS-CoV-2 in students and school staff; and to identify predictors of infection, including both municipal epidemiological indicators and individual variables reported by the participants.Methods This was a virological survey carried out among students (over 14 years old) and school staff in São Paulo state, between epidemiological weeks 43 to 49 of the year 2020. A self-administrated questionnaire including sociodemographic and clinical information was applied. Moreover, a nasopharynx swab was performed for virological testing (RT-PCR). We evaluate the relationship of COVID-19 epidemiological indicators of the residence municipality with the odds of SARS-CoV-2 infection. For this, a composite index relating recent mortality and previous incidence (RM/PI) was proposed based on the ratio of deaths recorded in the second and third week counted back to the sum of cases during the previous seven weeks (weeks 4 to 10 counted back). We obtained a multiple model using random-effects logit regression integrating epidemiological indicators and individual variables.Results In total, 3436 participants were included, residents of 72 municipalities. The overall prevalence of infection was 1.7% (95%CI: 1.3%-2.2%). SARS-CoV-2 infection was independently associated with loss of smell, a history of pulmonary disease, and a recent trip outside the municipality. Moreover, the RM/PI index consistently predicted the SARS-CoV-2 infection (adjusted OR: 1.45; 95%CI 1.02-2.04). Based on these associations, we proposed a classification in four groups with different SARS-Cov-2 infection prevalence (0.54%, 1.27%, 3.8%, and 4.13%).Conclusion Epidemiological and individual variables allowed classifying groups according to the infection probability in a school population of the state of São Paulo. This classification could help guide the return to classes in situations in which epidemiological control is evident, maintaining basic protection measures and increasing vaccination coverage.Competing Interest StatementThe authors have declared no competing interest.Funding StatementInputs, reagents and technical staff from the Strategic Diagnostic Laboratory and the Quality Control Center received financial support from the Butantan Foundation. FADQ was granted a fellowship for research productivity from the Brazilian National Council for Scientific and Technological Development - CNPq, process/contract identification: 312656/2019-0.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study followed Brazilian and International legislation for conducting human research. This research project was approved by the Research Ethics Committee of the School of Public Health of the University of Sao Paulo (Register number: 4.369.013 and CAAE: 38625120.3.0000.5421).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are available on request from the corresponding author.